You just read:

Aldeyra Therapeutics Announces Presentation of Novel Data on the Efficacy of ADX-102 in a Model of Succinic Semialdehyde Dehydrogenase Activity at the 2017 American Society of Human Genetics Annual Meeting

News provided by

Aldeyra Therapeutics, Inc.

Oct 05, 2017, 08:00 ET